Memantine Hydrochloride 28 mg/1 (Memantine Hydrochloride CAPSULE, EXTENDED RELEASE) 28 mg/1

Memantine hydrochloride 28 mg/1 is an extended-release capsule used to manage moderate to severe Alzheimer's disease symptoms. This medication works by regulating glutamate activity in the brain, potentially improving cognitive function and daily living activities.

Strength

28 mg/1

Pack Size

30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0615-8264-39)

Manufacturer / TM Owner

NCS HealthCare of KY, LLC dba Vangard Labs

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Memantine hydrochloride is primarily used to treat moderate to severe Alzheimer's disease. It is designed to slow the progression of symptoms by modulating glutamate, a neurotransmitter involved in brain function. This medication is often prescribed as part of a comprehensive treatment plan to help maintain cognitive abilities and independence.

Side Effects

Common effects of memantine hydrochloride may include dizziness, headache, and constipation. Some users might experience confusion or fatigue. These effects vary individually and typically subside as the body adjusts to the medication. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Memantine hydrochloride should be handled with care, especially for individuals with a history of seizures or severe liver or kidney disease. It is important to follow the prescribed dosage and administration instructions. Store the medication in a cool, dry place away from direct sunlight and out of reach of children.

Avoid Interactions

Memantine hydrochloride may interact with other medications, including certain antidepressants, anticonvulsants, and drugs that affect kidney function. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be minimized while using this medication.

Frequently Asked Questions

Memantine hydrochloride is used to manage symptoms of moderate to severe Alzheimer's disease by regulating glutamate activity in the brain.

Memantine hydrochloride is typically taken orally, with or without food, as directed by a healthcare provider. The extended-release capsules should be swallowed whole.

Common side effects may include dizziness, headache, and constipation. Some users might experience confusion or fatigue.

Memantine hydrochloride may interact with other medications, so it is important to consult a healthcare provider before combining it with other drugs.

Memantine hydrochloride should be stored in a cool, dry place away from direct sunlight and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.